Evidence map›Paper›PMID 33759507›Full record

ArticleEnvironmental science & technology2021

Feasibility of Lead Exposure Assessment in Blood Spots using Energy-Dispersive X-ray Fluorescence.

Aaron J Specht, John F Obrycki, Maitreyi Mazumdar, Marc G Weisskopf

Open access · greenAbstract read
In one paragraph

Article in Environmental science & technology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Energy dispersive X-ray fluorescence provides a new option for measuring arsenic, mercury, and lead in dried blood spots.Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Ways to Measure Metals: From ICP-MS to XRF.Current environmental health reports · 2025
    Review
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Aaron J SpechtHarvard T.H. Chan School of Public Health, 655 Huntington Ave Building 1 Rm 1402, Boston 02115-5724, Massachusetts, United States.ORCID 0000-0002-3342-1229
John F ObryckiDepartment of Neurology, Boston Children's Hospital, Boston 02115-5724, Massachusetts, United States.
Maitreyi MazumdarHarvard T.H. Chan School of Public Health, 655 Huntington Ave Building 1 Rm 1402, Boston 02115-5724, Massachusetts, United States.
Marc G WeisskopfHarvard T.H. Chan School of Public Health, 655 Huntington Ave Building 1 Rm 1402, Boston 02115-5724, Massachusetts, United States.
Boston Children's Hospital · USHarvard University · US

Funding

Translational Research Support CoreP30ES000002 · NIEHS · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI SUSAN A KORRICK · 1985 to 2026
$44.6M
NIEHS NIH HHS P30 ES000002NIOSH CDC HHS K01 OH011648
6 · The paper itself

Abstract

Collecting blood spots from newborns is a common procedure used to diagnose multiple health conditions. Fingerstick blood samples are routinely collected from children to diagnose elevated blood lead levels. In our study, we wanted to test the feasibility of using a high-power energy-dispersive X-ray fluorescence (EDXRF) device to accurately measure the concentration of lead in blood spots. We created spotted standards of a known concentration of lead on a filter paper at different volumes and concentrations. We determined the detection limit for lead through repeated measurements of our standards and calibration line slopes. We also tested the variability of the measured lead concentration across procedures and spotted blood volumes and found no significant additions to uncertainty in measurements. Finally, we compared blood lead concentrations measured by EDXRF and atomic absorption spectroscopy (AAS) and found EDXRF to be a significant predictor of blood lead (

Indexed as

LeadMultimorbidityChildCross-Sectional StudiesFeasibility StudiesHumansInfant, NewbornSpectrometry, X-Ray EmissionX-RaysLead

Identifiers

PMID33759507
PMCPMC10615324
OpenAlexW3136508532

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.